Networth Advisors
RPRX icon

Networth Advisors’s Royalty Pharma RPRX Stock Holding History

Networth Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.04K Hold
69
– – ﹤0.01% 253
2026
Q2 		$3.87K Buy
+69
New +$3.59K ﹤0.01% 252
2026
Q1 		– Sell
-68
Closed -$2.63K – 437
2025
Q4 		$2.63K Buy
+68
New +$2.59K ﹤0.01% 241

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
New South Capital Management
New South Capital Management Memphis, Tennessee $1.53B AUM 36.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Networth Advisors's RPRX Position: Q3 2026 in Review

Networth Advisors held its Royalty Pharma (RPRX) position steady in Q3 2026 at 69 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #253.

Networth Advisors first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 297 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Networth Advisors held 69 shares of Royalty Pharma worth $4.04K as of Q3 2026.
  • Networth Advisors left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up ﹤0.01% of Networth Advisors's portfolio in Q3 2026, its #253 holding.
  • Networth Advisors first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 297 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Networth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.